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Vocation: A Call to Action 
 “Vocation is from the Latin vocare, to call, and means the work a person is called to 
by God.” – Frederick Buechner 
Have you ever been awoken by the soft voice of a child who knows they ought 
to be sleeping, but are kept awake by the nightmares that ensnare their minds to the 
point they envision monsters hiding in every shadow? Did you happen to notice the 
helplessness in their eyes, the fear in their trembling voice, and did you not try to do 
everything in your power to ensure that they were safe, to get them to realize that the 
visions in their head are not real and as soon as they open their eyes the demons 
simply disappear. Now I ask, what would you do if you saw that same look in the 
eyes of a catatonic twenty-something young woman who just happened to catch a 
glimpse of a man, whose profile is vaguely similar to another’s who is serving fifteen 
years in prison? 
For her the demons are monsters from her past, whose actions have seared 
themselves into her memory grossly invading her present without so much as a 
warning. How are we supposed to help someone like her? Simply telling her that it is 
over is not enough for she has heard that repeated over and over like a song stuck on 
loop and it is short of impossible to try and console someone who recoils at the 
slightest touch. The worst about all of this is that I cannot say she is the exception to 
the rule, that this is a unique experience within our society. All one has to do is look 
around, at the homeless begging on street corners, to the solders in their war torn 
uniforms, to those how have seen their livelihoods swept away by forces of nature; 
because if you look closely enough you may be able to see the despair in the eyes of 
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those who suffer from what is commonly known as post-traumatic stress disorder 
(PTSD). 
Sadly, I happen to know an unfortunately high amount of people to suffer 
from PTSD. I know what it is like to help someone find their second set of earmuffs 
so they do not have to re-experience war during 4th of July celebrations, to talk 
someone back into the present, and honestly I was proud of myself because I believed 
that I was helping them to the best of my ability. However, entering into my senior 
year I felt a nagging in the back of a mind that was telling me that, maybe I could do a 
little bit more. 
It all finally clicked for me when a friend happened to mention the 
astonishingly high amount of veterans with PTSD who are living homeless in our 
nation’s major cities. Sure, I have seen these men and women panhandling on the 
street and tossed them extra change if I could but I never gave a second thought to the 
ordeals that they are going through, and I am someone who has seen first-hand how 
debilitating PTSD to someone’s livelihood. Furthermore, at least the people in my life 
have the support of their family and friends but these people are out fighting this 
disorder on their own with minimal resources. So I decided to join those whose 
research has been done in order to serve, not only veterans, but all people who suffer 
from PTSD. No longer shall I stand idle.   
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Abstract 
 The neurological pathways for posttraumatic stress disorder have come under 
scrutiny in recent years due to emerging research on the endocannabinoid system. 
Suggested involvement in the fear and stress pathways involve the pre-synaptic 
modulation of corticosteroid activity upon the consolidation and extinction of 
emotional memories in the hippocampus or the basolateral amygdala or possibly the 
GABA, 5-HT, and NE neuronal projections that are centered in the medial pre-frontal 
cortex that have been implicated in the hyperarousal and negative affect of PTSD. 
This study will focus on the use of anandamide, a CB1 and CB2 agonist in the 
treatment of PTSD behavioral symptoms of a rat model, specifically general anxiety, 
avoidance, generalization, and spatial learning and memory. It will also utilize 
immunohistochemistry to observe the neurochemical alterations that are facilitated by 
the onset of the disorder and subsequent treatment in regards to the cannabinoid 
receptor availability in the CA1 area of the hippocampus and basolateral amygdala. 
Rats were subjected to moderate unescapable foot shocks, paired with a predatory 
stressor and a novel stimulus, in conjunction with situational reminders in order to 
elicit and maintain PTSD symptomology. Anandamide was shown to significantly 
increase spatial memory functioning and moderately reduce avoidance behaviors, but 
did not have a significant effect on anxiety or generalization behaviors.  
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Introduction 
 Posttraumatic stress disorder (PTSD) is no longer the enigmatic disorder that 
had puzzled physicians of years past. It is no longer a diagnosis that is given under 
different names, such as Gulf War Syndrome, shell shock, or post-combat fatigue, but 
a single diagnosis that will be given to nearly a tenth of the general U.S. population 
and nearly a third of those who serve in the Armed Forces. However, while now that 
it is possible to recognize the disorder focus must be shifted towards the discovery of 
an underlying cause and possible treatments. 
The criterion for a PTSD diagnosis been outlined in the latest iteration of the 
Diagnostic and Statistics Manual (American Psychiatric Association, 2013), which 
separates them into five distinct categories. The first is that one must experience a 
trauma, either directly or through a close relation, which can range from combat 
experience to natural disasters to sexual assaults. While this criterion might seem 
obvious two meta-studies found that PTSD was found to be comorbid on average 
76% of the time with borderline personality disorder in women or dependent 
personality disorder in men, 66% of whom reported that they had never experienced a 
trauma (Ford et al., 2015). The second involves symptoms of invasive memories or 
thoughts which can manifest in ways ranging from vivid nightmares or uncontrolled 
flashbacks. Third, the patient must show avoidant behaviors which can include social 
withdrawal or simple everyday behaviors to avoid stimuli that are found to be 
noxious. The next criterion is that patients with PTSD present with negative affect or 
cognitions, which can be directed towards oneself or projected. Last is a state of 
hyper-arousal which can be expressed through the partaking in reckless behavior, 
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restlessness, or constant anxiety. A patient must display behaviors in all four of these 
categories for at least six months following exposure to the stressor to receive a 
diagnosis. 
The narrowing of symptoms to highly definable psychological categories is crucial 
because it has led to the discovery of the underlying neurological structures and 
chemicals that lend themselves to the clinical manifestation of the disorder. Through 
extensive research it has been shown that the four major neurological structures that 
have been correlated with PTSD and considered to be a part of the fear and stress 
circuit within the brain are, the basolateral amygdala (BLA), the hippocampal nuclei 
(CA1), the medial pre-frontal cortex (mPFC), and the hypothalamic-pituitary axis 
(HPA) (Hauer et al., 2014; Ford et al., 2015). Furthermore, the neurotransmitters 
involved are, glucocorticoids, GABA, serotonin (5-HT), and noradrenaline (NE) 
(Ford et al., 2015). However, the most effective pharmacological treatments (SSRI’s) 
that are based off the hypothesis that one or more of these systems are malfunctioning 
have only proven to be 60% effective at alleviation of initial symptoms and only 20% 
effective in assisting in full or partial clinical remission of the disorder (Neumeister et 
al. 2015). This suggests that critical information about the fear circuit. Recent studies 
(Ganon-Elazar & Akirav, 2013; Hauer et al., 2015; Neumeister, 2013) into how the 
endocannabinoid system interacts with all of the components of the fear circuit seem 
to point to endocannabinoids (eCBs) as being the previously missing, neuro-
modulatory, component.  
To fully understand the complexity and the role of cannabinoids in the regulation of 
the fear circuit one must look at the neurochemical control they exert in the four main 
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structures of the circuit. This is best done by examining the effects that eCBs have on 
the release of the known neurotransmitters (NT). 
 
Glucocorticoids 
 
Glucocorticoids (GCs) are known as the stress hormone as they are released via the 
HPA axis in response to stressful stimuli. What is unique about the relationship 
between eCBs and GCs as that it is bidirectional. It begins with the initial release of 
GCs causing a Ca++ cascade that activates the enzymes that convert lipid membrane 
into eCBs (Hillard, 2000). The eCBs then bind pre-synaptically and act as a 
feedforward mechanism facilitating the release of GCs, until a point where the 
buildup of both NTs causes eCBs to act as a feedback inhibitor and prevent any 
further release of GCs (Ganon-Elazar & Akirav, 2013; Neumeister, 2013; Evanson et 
al., 2010). Meanwhile GCs are up and down regulating the availability of eCB 
receptor (CB1 and CB2) availability, specifically in the BLA and hippocampus 
(Neumeister et al. 2013; Neumeister et al., 2015). Furthermore, a buildup of the GCs 
precursor, corticotrophin releasing hormone (CRH), activates fatty acid amide 
hydrolase (FAAH) which breaks down the eCBs in the synapse (Gray et al., 2015). 
Seemingly, both NT are required to maintain proper control and normal levels of the 
other (Cota et al., 2007). 
While these two NTs might assist each other chemically in regards to behavior, 
specifically aversive memory consolidation and extinction, they are the antithesis of 
each other. Synthetically increased levels of GCs in the BLA and hippocampus have 
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been shown to facilitate the consolidation, hinder extinction, and even re-consolidate 
conditioned fear responses (Campolongo et al., 2009). The injection of synthetic 
cannabinoids or inhibition of FAAH on the other hand has been shown to facilitate the 
extinction of aversive memories, without any psychoactive effects altering initial 
consolidation or conscious recall (Campolongo et al., 2009; Chhatwal et al., 2005; 
Bitencourt et al., 2013; Das et al., 2013). Interestingly, this effect is time dependent in 
that the injection only facilitates extinction if given hours after the exposure to the 
stressor, if given earlier it seems to have a preventative effect (de Oliveira et al., 
2008). This suggests that eCBs are effectively reducing the levels and effects of GCs. 
This idea is backed by evidence that CB1 receptors in the BLA are down-regulated 
and those in the hippocampus are up-regulated. These differing regulations would 
lead to smaller initial but chronic GCs activation in the BLA, which is consistent with 
the over activation theory of PTSD (Neumeister et al., 2013), and a short but initial 
flooding of the hippocampus, which could lead to the oxidative and subsequent 
atrophy seen in a majority of PTSD patients. 
It is important to note that while researchers still debate whether or not a reduced 
hippocampal size is evident of PTSD or if it is simply a risk factor, but they do agree 
that hippocampal dysfunction is present in patients with PTSD (Neumeister et al., 
2015). This is evidenced by the poor performance of PTSD patients and animal 
models of PTSD on spatial memory tasks. Therefore, it is possible that CBs could 
prevent or cause this damage depending on the regulation of their receptors. Overall, 
this evidence suggests that CBs could be used to facilitate the extinction of avoidance 
behaviors as well as the destruction of hippocampal neurons through the regulation of 
GCs in the brain. 
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GABA 
 
Through years of research it has been shown that GABA acts as the main inhibitory 
NT in the brain. Ford et al. (2015) explains that the main GABAminergic projections 
in the fear and stress pathway begin in the mPFC and terminate in the BLA. They 
suggest that the over-activation of the amygdala might be due to a lack of inhibitory 
signals by the mPFC which can result in the lack of ability to distinguish between a 
potentially dangerous or harmless stimulus (Lin et al., 2009). Lin et al. (2009) and 
Ratano et al., (2014) have shown that the activation of novel CB receptors by the 
synthetic cannabinoid, cannabidiol CBD, on the GABAminergic neurons could 
potentially assist in the release of the NT and potentiate the inhibition of BLA 
activation. This suggests that CBs could potentially reduce the amount of generalizing 
behavior by reducing the amount of BLA activation. 
 
Serotonin & Noradrenaline 
 
 While the interconnectedness of the serotonin and noradrenergic and the 
cannabinoid system has not been as extensively researched as the previous systems, 
recent discoveries show promising results. 
 The NE neurons in the mPFC are utilized to activate the bodies sympathetic nervous 
system (SNS) which controls arousal states (Morilak, 2012). The injection of CBD 
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into the mPFC has shown to decrease arousal when administered after exposure to a 
stressor, but increases it if given prior to exposure (Fogaça et al., 2014). This suggests 
that the eCB modulation of NE could be similar to that of GCs and be used to reduce 
hyperarousal-induced anxiety.  
The 5-HT neurons in the mPFC are related to emotional control, expressly depressive 
behaviors. Marinho et al., (2015) and Sartim et al., (2016) directly injected CBD into 
the mPFC of rats, after extended periods of inescapable restraint, and found that it 
reduced depressive symptoms. Furthermore, they showed that this effect could be 
blocked via the co-injection of a 5-HT antagonist. This suggests that the pre-synaptic 
activation of CB receptors could be utilized to reduce negative affect and related 
negative cognitions. 
This study attempts to determine the effectiveness of using cannabinoids as a 
treatment for PTSD symptoms by targeting the areas of interaction outlined above. It 
will utilize the eCB, anandamide which is the intrinsic activator of CB1 and CB2 
receptors, to provide insight as to whether or not CB are a viable target for future 
synthetic pharmacological interventions.  
This study will induce PTSD in a rat model so that the symptoms developed will be 
comparable to those laid out for humans in the DSM 5 but still adhering to reactions 
that can be observed in nature for the selected animal model as presented by Ford et 
al. (2015). It will also attempt to observe all changes made to all behaviors related to 
PTSD in regards to the pharmacological interventions. 
This study suggests that the cannabinoid system act in a neuro-modulatory fashion 
within the fear and stress pathways and that it is the disruption of this system that is at 
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the center of PTSD symptomology. Furthermore, the application of cannabinoids 
should restore the cannabinoid control of glucocorticoid, GABA, NE, and 5-HT 
release which should reduce the clinical presentation of their related symptomologies. 
My hypotheses are that (1) rat behaviors, such as anxiety, avoidance, and 
generalization, will be increased, while spatial memory will decrease due to the 
application of the stressors. (2) Any behavioral changes due to the trauma will be 
alleviated by the application of the pharmacological intervention of anandamide. (3) 
The regimented administration of the pharmacological intervention. (4) There will a 
downregulation of CB1 and CB2 receptors in the hippocampus and an upregulation of 
receptors in the basolateral amygdala with the application of anandamide in 
comparison to the control. 
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Methods 
All procedures were carried out under strict compliance with ethical 
principles and guidelines of the NIH Guide for the Care and Use of 
Laboratory Animals. All treatment and testing procedures were approved by 
the Intuitional Animal Care and Use Committee of Regis University in 
Denver, Colorado.  
 
2.1. Animals 
 
Adult, male Charlie-River rats will be used throughout the study. The 
animals were housed singly or in pairs in a cage with a width of 25 cm, a 
length of 45 cm, and a height of 25cm. The conditions in the animal facility 
will be stabilized at room temperature. The animals were in an environment 
with a twelve-hour alternating light/dark cycle with the light being initiated 
at 6:00 and dark at 18:00. All animals had food and water available ad libitum. 
The cage bedding was changed every three days. All subjects were allowed to 
adjust to their environment for a week before experimentation began.   
 
2.2. Experimental design 
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This study consisted of four main experiments, three of which assessed 
the effectiveness of anandamide as a treatment through the observation of 
differing behavioral symptoms of post-traumatic stress disorder in an animal 
model. The fourth was a brain imaging study that utilized 
immunohistochemistry to analyze the differentiation of cannabinoid receptor 
availability in the basolateral amygdala and hippocampus between the 
control and experimental groups. The independent variable is treatment 
levels. The first facet being that the rats were either controls and given a saline 
injection or in the experimental groups and given anandamide. The second 
facet is treatment regimen, where one experimental group received a single, 
initial injection and the other experimental group received weekly injections 
in addition to the initial injection post stressor. The dependent variables are 
the subjects’ performance on an elevated plus maze, a modified elevated plus 
maze, a Morris water maze, and qualitative levels of cannabinoid receptors in 
the hippocampus and amygdala.  
 
2.3 PTSD Model Induction 
 
Due to the increase in funding for PTSD research since the 1990’s there 
has been multitudes of research protocols developed for the production of 
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PTSD symptoms in animal models (Campos et al.. 2013; Corral-Frias et al., 
2013). This experiment integrated the most replicable aspects of each model in 
order to constructively and consistently induce a rat model of PTSD.  
PTSD was induced one and a half weeks after the subjects were 
randomly assigned to either of the two experimental groups or the control 
group, allowing them to acclimate to the possible stressors of being handled 
in the animal facility. For the experimental application of stress, the rats were 
first placed in a bright white chamber and allowed to acclimate to it for 5 
minutes. This chamber served as the situational reminder, which has shown 
to increase the duration of behavioral symptoms of PTSD under experimental 
conditions without causing extinction of behavior through placing the rat in 
the operant chamber without shocks (Korem &Akirav, 2014; Louvart et al., 
2005; Pynoos et al., 1996). The rat was then placed in a darkened standard 
operant chamber and allowed to acclimate for thirty seconds. Then an 
unavoidable foot shock was applied (1.5 mA intensity, 0.5 sec duration) 
randomly every 30 seconds for a total of 10 minutes in combination with a 
predatory stressor (Korem &Akirav, 2014). Exposure to a novel object, a 
yellow soft-flight golf ball, was included during the stressing environment 
and was later utilized as an aversive stimulus in the modified elevated plus 
maze. 
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All subjects will receive treatment of either anandamide (5mg/kg) or an 
equivalent amount of 9% saline solution via i.p. injections two hours after the 
initial stressor event. Additionally, one of the experimental groups received 
weekly injections of anandamide (5mg/kg) starting one day following 
situational reminder testing. 
 
2.3.1 Situational Reminder 
 
All subjects were placed back in the original bright white chamber, for 
one minute, 3 and 5 days after the initial stressor which acted as a situational 
reminder. The rats were not exposed to either the stress chamber or the novel 
object, soft-flight golf ball, in order to prevent situational extinction of the 
aversive memory (Korem &Akirav, 2014; Louvart et al., 2005; Pynoos et al., 
1996). Their activity within the chamber was observed by the experimenter 
but not recorded. 
 
2.4. Chemicals 
 
 Anandamide is one of two known neurotransmitters that is lipid in 
nature and therefore cannot be directly injected or directly dissolved in saline 
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solution. Therefore, the anandamide (5mg/kg) was first emulsified in DMSO 
(10g/mL) and then mixed with enough 0.9% saline solution, which acted as a 
vehicle, to achieve ± 5% concentrated dose which was given intraperitoneally 
at a volume of 1.5mL per kg of weight. The control rats were given a similar 
dose of just the vehicle, 0.9%saline solution, as it has been previously shown 
that DMSO has no behavioral effects on rats in a PTSD model up to 
concentrations well above 10% (cite) and it reduces the chance of accidently 
using a contaminated chemical. Due to the nature of the synthesis the 
anandamide was emulsified and placed in the vehicle the day of the initial 
stressor and was covered and refrigerated in between injections, and allowed 
to reach room temperature before being injected.  
 
2.5. Behavioral Testing 
 
In order to analyze the behavioral symptoms of general anxiety, 
avoidance, and generalization the subjects were tested on their performance 
on the elevated-plus maze and modified elevated plus maze, 7 and 28 days 
and 14 and 28 days respectively, after the initial stressor event. The subjects’ 
spatial learning performance on the Morris Water maze was tested 10 days 
following the last situational reminder trial, and a probe trial to examine 
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spatial memory was conducted 10 days following the last spatial learning 
trial. All observations and recordings were made by the primary investigator.  
 
2.5.1. Elevated Plus Maze 
 
The Elevated Plus Maze (EPM) (Figure 1) is a common behavioral test 
utilized to assess the subjects’ general anxiety levels following a stressor and 
in this study subsequent situational reminders (Gobira et al., 2013). The 
ideology behind the EPM is that it contrasts the subjects’ natural exploratory 
behavior against its desire to protect itself and that the more anxious the 
subject is, the more it will want to be protected and therefore the more time it 
will spend within the closed arms of the maze. The EPM consists of four arms 
with a length of 80 cm and a width of 6 cm that are suspended 60 cm off of the 
ground. Two of the arms are enclosed on the sides and end, were darkened 
using black construction paper, and given the designation of closed and the 
others were not enclosed at all and designated as open. There was also 
depressed area of the maze, 6 cm x 6 cm, in the center where all four arms 
connected which was considered as a neutral space. At the beginning of 
testing all subjects were placed in the neutral space facing the open arm away 
from the experimenter and allowed to roam freely throughout the maze and 
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the time spent in the arms is recorded. The subject was considered to be 
located on an arm when all four legs had crossed the line that separated the 
arm from the neutral space. The time that was spent in the neutral space, 
when all four legs were within the separatory boundaries, was recorded as its 
own location rather than being in either a closed or open leg. The subjects’ 
anxiety level was then recorded as a ratio determined by the amount of time 
spent in the closed arms of the maze in relation to the total time spent in the 
maze.  
2.5.2. Modified Elevated Plus Maze 
 
 The Modified Elevated Plus Maze (MEPM) is identical to the EPM in 
all dimensional aspects except that in the corner of one of the closed arms is 
the yellow soft-flight golf ball that was presented during the stressor period 
as the paired stimulus, and in the opposite arm is another soft-flight golf ball 
that is similar in all aspects except that it is orange, as an unpaired stimulus 
(Figure 2). The object placement This test assesses the subjects’ avoidance 
behavior in regards to an aversive stimuli and to see of the stressor was 
strong enough to cause the generalizability of aversive stimuli often seen in 
subjects of classical conditioning. While previous studies (Kniss, 2012) utilized 
ball burying behavior to assess avoidance behaviors, it has been pointed out 
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that this behavior has only been intermittently observed under strictly 
experimental conditions and is not believed to consist of any natural 
behaviors.  
The MEPM on the other hand allows for the subjects’ to physically avoid the 
paired stimulus by escaping to an arm of the maze that does not contain the 
object. As in the EPM, all subjects were started by being placed in the neutral 
area of the maze facing the open arm opposite of the experimenter and 
allowed to roam freely for 5 minutes. However, time spent in the closed arm 
with the paired object was recorded separately from the time spent in the 
closed arm with the unpaired object. 
The subjects’ avoidance behavior will be assessed via an avoidance 
ratio which will analyze the amount of time that they spend outside of the 
arm that contains the paired object in regards to the total amount of time that 
is spent in the maze. Furthermore, if the subjects’ attempt to avoid both the 
paired object and the unpaired object then one may assume that the stressor 
event lead to the generalization of the paired object, which could be 
instrumental in understanding the symptomology of PTSD. The subjects’ 
generalization behavior will be assessed via a generalization ratio which will 
analyze the amount of time spent on either the open arms or neutral space in 
regards to the total time that is spent in the maze.  
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2.5.3 Morris Water Maze 
 
Ford et al. (2015) have shown that damage or alterations to the 
hippocampus caused by stressing events have also been shown to affect 
scores on spatial learning and memory. The Morris Water Maze (MWM) was 
used to assess the subjects’ spatial learning and memory. The maze is a black 
circular tub that is 165 cm in diameter and was filled to a depth of 80 cm. Yarn 
was then suspended above the maze to section it into four separate quadrants 
which were then arbitrarily given designations that correspond to locations 
upon a compass for use of reference throughout the entirety of the experiment 
(Figure 3). Novel pictures of differing shapes and colors were then placed on 
specific points throughout the experimentation room so that they could 
possibly be used as location references. Finally, a stand was placed in the East 
quadrant so that it was submerged about 1 cm beneath the water’s surface 
and concealed by making the water slightly opaque with powdered milk. 
Testing began by placing the subject in a quadrant about 3cm from and facing 
the wall and allowing them to freely explore the maze. The time it took the rat 
to find the platform was recorded, and if they could not find it within a 
minute they were gently guided to the platform and allowed to stand on it for 
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ten seconds. All subjects were started in each of the four quadrants per day, 
starting in the West and rotating clockwise, and were tested over four days 
resulting in a total of 16 trials per rat. 10 days following the last acquisition 
trial, a probe trial was run to assess the subjects’ spatial memory. Like the 
learning trials the subjects were started 3cm from and facing the outer wall, 
however they were only tested from the West quadrant and the platform had 
been removed. The amount of time each rat had spent in the target quadrant, 
which was determined by the whole body, excluding the tail, crossing the 
dividing lines, was then recorded. 
2.6. Immunohistochemistry 
After experimentation was completed all subjects were euthanized via 
i.p. injection of euthasol (150 mg/kg) and their brains allowed to fix in 9% 
para-formaldehyde for 24 hours. The brains were then transferred into a 25% 
sucrose solution in PBS. The brains were then placed in a cryostat and sliced 
30 microns thick and then placed and allowed to freely float in 2 mls wells. 
For labeling of CB receptors slices were first rinsed with 0.1 M PBS and later 
in combination with 0.2% Triton-X, between which blocks for endogenous 
peroxidases and non-specific blocks were applied. They were then placed into 
a solution containing 2% NGS, and the primary antibodies (Millipore, 209550-
100Ul Anti-Cannabinoid Receptor CB1 (1-77), Lot D00175686) at a 1:1000 
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dilution and then allowed to incubate overnight at 4°C. After incubation and 
rinse, the slices were incubated in the secondary antibodies (Vector, BS 1000 
Biotinylated Goat Anti-Rabbit, Lot C 12 03) at a dilution of 1:200. They were 
then immersed in ABC solution (ABC Elite Kit, Vector, PK-6100) for 
amplification and then rinsed. Finally, they were placed in DAB (DAB 
Peroxidase Substrate Kit, Vector, SK-4100) until visibly stained. Once rinsed 
slices were then placed on slides and allowed to dry before characterization. 
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Results 
 
All data were evaluated for skewness and kurtosis to identify whether 
or not the data were normalized, which is an intrinsic assumption made by 
the SPSS software. If the data were not normal box plots were used to identify 
outliers for removal, after which skewness and kurtosis were ran again until 
population was normalized to ensure more accurate interpretation of the 
data. 
3.1. Elevated Plus Maze 
 The elevated plus maze assessed the degree of anxiety exhibited by the 
subjects’ post-stressor. The anxiety ratios were analyzed for both the effects of 
treatment, treatment or no treatment and treatment regimen, and time. 
 Using a repeated measures generalized linear model, this study found 
no main effects of treatment or time on the anxiety ratios. The mean anxiety 
ratios at 7 days post-stressor were, .407 ± .322 for the control, .744 ± .116 for 
the initial injection group, and .692 ± .133 for the multiple injection group 
(Figure 4). The mean anxiety ratios at 28 days post-stressor were, .683 ± .421 
for the control group, .690 ± .373 for the initial injection group, and .772 ± .233 
for the multiple injection group (Figure 4). The main effect of time was not 
significant on the anxiety ratios recorded, F(1,20) = 1.888, p= .185. The main 
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effect of treatment was not significant, F(2,20) = 1.505, p=.246. There was no 
significant interaction between time and treatment on anxiety, F(2,20)  = 1.493, 
p = .249. 
3.2. Modified Elevated Plus Maze 
 The modified elevated plus maze assessed the avoidance and 
generalization behaviors exhibited by the subjects’ post-stressor. The 
avoidance and generalization ratios were analyzed for both the effects of 
treatment, no treatment or treatment and treatment regimen, and time. Using 
a repeated measures general linear model, this study found marginal main 
effects of treatment and time on avoidance ratios, but no significant 
interaction between the two.  
 The mean avoidance ratios at 14 days post-stressor were, .900 ± .10494 
for the controls, .758 ± .180 for the initial injection group, and .752 ± .099 for 
the multiple injection group (Figure 5). The mean avoidance ratios at 28 days 
post-stressor were, .767 ± .309 for the control group, .728 ± .270 for the initial 
injection group, and .495 ± .282 for the multiple injection group (Figure 5). 
There was a marginal main effect of time on avoidance ratios, F(1,19) = 3.720, 
p =.069. A post hoc Bonferroni analysis showed that avoidance ratios were 
.140 lower at 28 days post-stressor than they were at 14 days. There was also a 
marginal main effect of treatment on avoidance ratios, F(2,19)= 3.010, p =.073. 
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There was, however, not a significant interaction between time and treatment 
on avoidance ratios, F(2,19)= 1.160, p=.335. 
 Using a repeated measures generalized linear model this study found a 
marginal main effect of time, but no main effect of treatment on generalizing 
ratios. The mean generalization ratios at 14 days post-stressor were, .370 ± 
.432 for controls, .415 ± .337 for the initial injection group, and .1877 ± .091 for 
the multiple injection group (Figure 6). The mean generalization ratios at 28 
days post-stressor were, .2134 ± .180 for controls, .308 ± .341 for the initial 
injection group, and .130 ± .103 for the multiple injection group. There was a 
marginal main effect of time on generalizing ratios, F(1,18) = 4.201, p=.055. A 
post hoc Bonferroni analysis showed that the generalization ratios at 28 days 
post stressor were .107 lower than those 14 days.  There was no main effect of 
treatment on generalizing ratios, F(2,22) = 1.285, p =.301. There was also no 
significant effect of the interaction between treatment and time on the ratios, 
F(2,18) = .254, p=.778. 
3.3. Morris Water Maze 
 The Morris water maze consisted of two separate testing periods, the 
first of which assessed the subjects’ spatial learning, and the second of which 
assessed their spatial memory. Acquisition training scores were analyzed for 
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effects of both time and treatment, and the probe trial was analyzed for effects 
of treatment. 
 Using a repeated measures generalized linear model, this study found 
a significant main effect of time but did not find a main effect of treatment on 
spatial learning.  There was a significant main effect of time on spatial 
learning trials F (15,330) = 10.649, p <.001. After establishing significance, a 
post-hoc Bonferroni test was applied which showed that all subjects took 
significantly longer to find the platform on trial 1, 20.597 sec, then all other 
tests except for trial 2, p<.010 and p=.582, respectively. It also showed that the 
subjects took significantly longer times on trial 2 than on trials 8,11,15, and 16, 
p<0.028. There were no significant differences between all other trials, p=1.000. 
There was no main effect of treatment on acquisition training F (2,22) = 1.000, 
p=.384. There was no effect of the interaction of between treatment and time 
on the acquisition trials F (2,22) = 1.549, p=.257. 
Using a one-way ANOVA, this study found a significant main effect of 
treatment on spatial memory. The mean times that the subjects spent in the 
target quadrant were, 20.48 ± 4.23 for controls, 23.51 ± 2.71 for the initial 
injection groups, and 29.93 ± 7.42 for the multiple injection group (Figure 7). 
There was a significant main effect of treatment on the probe trial, F(2,22) = 
6.291, p=.007. A post-hoc Bonferroni test showed that the multiple injection 
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group stayed in the target quadrant significantly longer than both the control, 
p=.012, and initial injection groups, p=.041, 9.45sec and 3.03sec respectively. 
There was not a significant difference between the control and initial injection 
groups, p=.940.    
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Discussion 
4.1. Elevated Plus Maze 
 The main results of the Elevated Plus Maze suggest that the 
administration of cannabinoids do not reduce the general anxiety levels of 
rats who have been exposed to stressors. Furthermore, results show that time 
also does not produce any significant change in anxiety levels.  
 While these results seem to conflict with some of the results of current 
literature that show that cannabinoids should be anxiolytic the discrepancy 
between them could be explained in two different ways. The first being that 
the waiting period between the trauma and the initial injection was not long 
enough and accidently ended up producing the anxiogenic effects that were 
seen in Fogaça et al., (2014). Since none of the other behavioral tests seemed to 
be affected by this reversal of expectations, it might be possible that the 
cannabinoid modulation of the NE receptors in the mPFC is through a novel 
mechanism and not the proposed regulation of glucocorticoids. This 
undefined mechanism might be related to uncharacterized cannabinoid 
receptors in the brain that have higher affinity binding for synthetic 
cannabinoids like CBD which are not direct CB1 agonists. 
 The second explanation correlates to the structures involved in the 
activation of the SNS. While studies have shown that cannabinoids have an 
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anxiolytic effect, the majority of them have centered on eCB activity in the 
mPFC and not ones in the locus coeruleus. It is possible that the anandamide 
was not able to fully activate the GABA inhibition of the amygdala, which 
would have led to an increase in arousal even if anandamide was modulating 
the transmission of NE from the mPFC. 
 Experimentally testing these two theories would actually be quite 
simple. The first experiment would consist of varying the time of the initial 
injection from beginning just after the exposure to a stressor to more than 24 
hrs following it. This would allow one to see if the presentation of anxiety is 
dependent upon the time of injection. For the second experiment one would 
have to inhibit the locus coeruleus while applying the cannabinoids and if 
there is a anxiolytic effect than you could assume that it was due to activation 
in the mPFC and if not you could say that it might not be the activation of 
CB1 receptors that result in the modulation of anxiety, but rather some other 
cannabinoid receptor. 
 
4.2. Modified Elevated Plus Maze 
 
 The main findings of the Modified Elevated Plus Maze are that time 
has marginal main effects on avoidance and generalization behavior whereas 
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cannabinoids only have a marginal main effect on avoidance behaviors. This 
suggests that avoidance and generalization behavior might have a cognitive 
component to it that allows for the behaviors to be reduced over time. 
However, it also shows that the injection of cannabinoids does facilitate in the 
reduction of avoidance behavior. 
 The reduction in the avoidance behavior can be due to three different 
mechanisms (Neumeister et al., 2015). The first is that the cannabinoids act 
directly upon the BLA, reducing the levels of GC’s facilitating in the complete 
extinction of the traumatic memory. Secondly, the cannabinoid could be 
activating the GABAminergic neurons in the brain bolstering the suppression 
of BLA activity resulting in the conscious differentiation between the stimuli. 
Lastly, the cannabinoid could be acting upon the hippocampus and through 
GCs control, allowing for the correct contextual information about the 
traumatic event to be projected to the mPFC. 
 Since the injection of anandamide did not have a significant effect upon 
the generalization behavior of the subjects one could assume that they are not 
acting within the mPFC to facilitate conscious differentiation. However, if one 
wanted to pinpoint the precise area of action they would most likely need to 
utilize micro dialysis to detect which cortical area has lower levels of GCs or 
through the cortical injection of synthetic cannabinoids. 
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4.3. Morris Water Maze 
  
 The main findings of the Morris Water Maze are that cannabinoids 
increase spatial memory as evidenced by increased time in the target 
quadrant. This finding is substantial because atrophy and dysfunction in the 
hippocampus is a hallmark of PTSD and if cannabinoids are able to have any 
preventative measures against that, they could be considered as good 
candidates for clinical use. This candidacy is bolstered by the data that shows 
that cannabinoids do not effect spatial learning, a negative side effect that is 
flaunted by public media and had it been proven could have dangerous 
consequences (Das et al., 2013; Goodman & Packard, 2015; Varvel& Lichtman, 
2002). Furthermore, since the increase in spatial memory is fairly conclusive of 
eCB activity within the hippocampus, there is more evidence that the 
marginal significance that was found in the MEPM related to avoidance 
behavior might be due to increase contextual information being able to be 
projected from the hippocampus.   
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Conclusion 
Overall, the data significantly or marginally supports the hypothesis 
that exposure to stressors cause worsening PTSD like symptoms in animal 
models, and that the systemic application of cannabinoids helps to reduce 
those symptoms. It does not support the idea that any level of cannabinoid 
would help in alleviating the symptoms of PTSD as in many of the tests there 
was no difference between the control and initial injection groups. So, taking 
it at face value the data is evidence in support of the idea that the 
dysregulation of the cannabinoid system might be at the center of PTSD 
symptomology, and that the administration of cannabinoids might be the 
answer to providing full clinical remission to all of its sufferers.  
 However, interesting questions are not the ones that the data answers 
but the ones they ask. While this study has shown that cannabinoids do work 
at alleviating PTSD the focus should now be shifted onto how/why they 
work. This study has laid the groundwork, the big picture if you will, for 
going back and looking at sections of the interaction between cannabinoids 
and the fear circuit piece by piece in order to more clearly define the 
pathways in which cannabinoids could be used to reduce PTSD 
symptomology or even lead to its prevention. 
 Going forward, research should include video analysis of all 
behavioral testing for greater accuracy to prevent larger than desired 
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confidence intervals and prevent researcher fatigue. Future research should 
also add a behavioral test for depression so that negative mood and cognition 
may be observed in conjunction with the other symptoms. 
 In conclusion, while this study barely scratched the surface of what 
could be the cannabinoid theory of PTSD, it provides some evidence that 
cannabinoids could be a viable candidate for clinical purposes and contributes 
to the ever expending knowledge of the neuroscience and PTSD research 
fields. 
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Figure 1.-Aerial view of the Elevated Plus Maze. Note that the apparent 
curvature is due to the construction paper and not an altered flooring 
angle 
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Figure 2.– Detailed images of an example orientation and location of stimuli in the 
Modified Elevated Plus Maze 
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Figure 3.– Image of the Morris Water Maze with gridlines and subject for reference 
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igure illustrates the mean anxiety ratios for all treatment levels on the Eleveated 
Plus Maze at 7 and 28 days post-stressor. There is no significant main effect of 
treatment level, F (2,20)= 1.505, p=.246,  or time F (1,20)= 1.888, p=.185. There was 
also no significant interaction bewteen the variables, F(2,20)= 1.493, p=.249.
Figure 4. - This figure illustrates the mean anxiety ratios for all treatment levels on 
the Elevated Plus Maze at 7 and 28 days post-stressor. There is no significant main 
effect of treatment level, F (2,20)= 1.505, p=.246,  or time F (1,20)= 1.888, p=.185. 
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164. There was not, however, a significant interaction between treatment and 
time, F (2,19)= 1.160, p=.335.
Figure 5. This figure illustraits the mean avoidence ratios for all treatment conditions 
at 14 and 28 days post-stressor. There was a marginal main effect of treatment, F 
(2,19)= 3.010, p=.071, η 2 = .241. There was also a marginal main effect of of time, F 
(1,19)=3.720, p=.069, η 2 = .164.. 
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Figure 6.- This figure illustrates the mean generalizing ratios for all treatment 
condition on the Modified Elevated Plus Maze at 14 and 28 days post-stressor. This 
study found a marginally significant main effect of time, F (1,18)= 4.201, p=.055. 
This study found no main effect of treatment, F (1.285)= 1.285, p=.301 
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Figure 7.- This figure illustrates the mean time that the subjects in each of the 
treatment groups spend in the target quadrant of the Morris Water Maze during the 
probe trial. This study found a significant main effect of treatment, F (2,22)= 6.291, 
p=.007 
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